The Trump administration reportedly is bothered by the $18.9 billion trade deficit with Switzerland, which is mainly driven by pharmaceuticals.
While the tariffs do not appear to be an immediate threat, they could potentially affect Swiss pharma giants Novartis and Roche and other manufacturers that produce drugs in Switzerland, like Merck and Biogen.
Read the full report here.
More articles on pharmacy:
Novant Health to open health clinics inside Walgreens
GlaxoSmithKline recalls prescription heartburn drug globally
BIO CEO to step down at the end of 2020
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.